FR3076997B1 - Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin - Google Patents

Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin Download PDF

Info

Publication number
FR3076997B1
FR3076997B1 FR1870047A FR1870047A FR3076997B1 FR 3076997 B1 FR3076997 B1 FR 3076997B1 FR 1870047 A FR1870047 A FR 1870047A FR 1870047 A FR1870047 A FR 1870047A FR 3076997 B1 FR3076997 B1 FR 3076997B1
Authority
FR
France
Prior art keywords
extract obtained
prevention
treatment
inflammatory bowel
chronic inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1870047A
Other languages
English (en)
Other versions
FR3076997A1 (fr
Inventor
Sebastien Peltier
Pascal Sirvent
Yolanda Otero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Clermont Auvergne
Valbiotis SA
Original Assignee
Universite Clermont Auvergne
Valbiotis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Clermont Auvergne, Valbiotis SA filed Critical Universite Clermont Auvergne
Priority to FR1870047A priority Critical patent/FR3076997B1/fr
Priority to US16/962,277 priority patent/US11712056B2/en
Priority to PCT/EP2019/051227 priority patent/WO2019141802A1/fr
Publication of FR3076997A1 publication Critical patent/FR3076997A1/fr
Application granted granted Critical
Publication of FR3076997B1 publication Critical patent/FR3076997B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'objet de l'invention est une composition comprenant au moins un mélange de molécules constitué au moins : - par un extrait unique obtenu à partir d'au moins Chrysanthellum indicum, Cynara scolymus et Vaccinium myrtillus et Piper, et/ou - par un extrait unique obtenu à partir d'au moins Chrysanthellum indicum, Cynara scolymus et Vaccinium myrtillus et par de la pipérine synthétique, pour une utilisation comme médicament ou produit de nutrition dans la prévention et/ou le traitement des maladies inflammatoires chroniques de l'intestin chez l'être humain ou l'animal.
FR1870047A 2018-01-19 2018-01-19 Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin Active FR3076997B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1870047A FR3076997B1 (fr) 2018-01-19 2018-01-19 Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
US16/962,277 US11712056B2 (en) 2018-01-19 2019-01-18 Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases
PCT/EP2019/051227 WO2019141802A1 (fr) 2018-01-19 2019-01-18 Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1870047A FR3076997B1 (fr) 2018-01-19 2018-01-19 Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
FR1870047 2018-01-19

Publications (2)

Publication Number Publication Date
FR3076997A1 FR3076997A1 (fr) 2019-07-26
FR3076997B1 true FR3076997B1 (fr) 2020-01-03

Family

ID=63209604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1870047A Active FR3076997B1 (fr) 2018-01-19 2018-01-19 Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin

Country Status (3)

Country Link
US (1) US11712056B2 (fr)
FR (1) FR3076997B1 (fr)
WO (1) WO2019141802A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900017555A1 (it) * 2019-09-30 2021-03-30 Dymalife Res S R L Associazione per uso nel trattamento e prevenzione di disturbi infiammatori del tratto intestinale
KR102514975B1 (ko) * 2020-08-18 2023-03-30 바이오스펙트럼 주식회사 이소오카닌을 유효성분으로 포함하는 민감성 피부용 조성물
IT202100002735A1 (it) 2021-02-08 2022-08-08 Phytoitalia Srl Metodo di estrazione e arricchimento di flavonoidi monoglicosilati da chrysanthellum indicum per il trattamento di patologie poliartritiche su base infiammatoria, per l'uso in dispositivi cosmetici, nutraceutici, medici e applicazioni farmaceutiche
GR1010519B (el) * 2022-07-04 2023-08-10 Νικολαος Τυμπανιδης Καταπινομενο σκευασμα για τονωση της ζωτικοτητας, της αντοχης και της γενικοτερης ευεξιας των ανδρων
CN115645429B (zh) * 2022-12-12 2023-05-16 汤臣倍健股份有限公司 一种花色苷组合物及其应用
CN116832109A (zh) * 2023-03-27 2023-10-03 南京鼓楼医院 一种低剂量重楼皂苷调节tnbs免疫应答的方法
CN116270822B (zh) * 2023-04-21 2024-03-15 广东冠清柠生物科技有限公司 一种缓解肺部纤维化的植物提取物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627376A1 (de) 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
US20040219232A1 (en) * 2003-02-06 2004-11-04 Zengen, Inc. Methods and compounds for treating malabsorption diseases and inflammatory conditions of the gastrointestinal tract
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
EP2135616B1 (fr) * 2008-06-19 2016-05-04 Symrise AG Fruit d'airelle séché destiné à influencer l'état de l'intestin
KR101686719B1 (ko) * 2011-11-29 2016-12-14 가부시키가이샤 아미노 압 가가쿠 진경제 및/또는 위장관운동 촉진제 용도의 비세닌 2 및 이의 유사체
ITMI20131815A1 (it) * 2013-10-31 2015-05-01 Fattoria La Vialla Di Gianni Anton Io E Bandino L Uso antinfiammatorio di fitocomplessi liquidi da olive
CN103690537A (zh) * 2013-12-17 2014-04-02 中国人民解放军军事医学科学院放射与辐射医学研究所 一种胡椒碱的药物新用途
FR3027228B1 (fr) * 2014-10-20 2016-12-09 Valbiotis Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
WO2016156527A1 (fr) * 2015-03-31 2016-10-06 International Nutrition Research Company Composition pour le traitement d'un etat metabolique pathogene du microbiote intestinal et des maladies derivees

Also Published As

Publication number Publication date
US11712056B2 (en) 2023-08-01
WO2019141802A1 (fr) 2019-07-25
FR3076997A1 (fr) 2019-07-26
US20200359670A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
FR3076997B1 (fr) Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
FR3027228B1 (fr) Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
FR3097122B1 (fr) Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin
FR2393531A1 (fr) Compositions fongicides pour l'agriculture a base de derives de 4-aminoquinazoline
RU2010122170A (ru) Композиции и способы улучшения состояния кожного покрова и шерстного покрова
Wright et al. Dry age-related macular degeneration pharmacology
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
FR3065876B1 (fr) Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
WO2018176079A8 (fr) Alcaloïdes berbérine dans la prévention et/ou le traitement d'une maladie intestinale
WO2022106897A3 (fr) Procédés et composition pour effectuer des modifications de kras
WO2017002840A1 (fr) Composition pour antagoniste de récepteur d'endothéline
DE69804597D1 (de) Salbe zur behandlung von verbrennungen und anderen hautkrankheiten
KR20060089201A (ko) 뽕잎을 투입한 축산방법
Altawil et al. Analgesic, Antipyretic and Anti-Inflammatory Activities of the Egyptian Spitting Cobra, Naja Nubiae Venom
FR3097740B1 (fr) Bactérie de la famille des Christensenellacées et composition en contenant pour la prévention et/ou le traitement d’une perte de masse musculaire pathologique ou d’une maladie caractérisée par une perte de masse musculaire pathologique
FR3066392B1 (fr) Composition a base de constituants vegetaux pour le soin ou le traitement de la peau et/ou des poils chez les animaux
DE202017004472U1 (de) Verwendung von Cistus mit Öl als Repellent gegen Zecken
MA53135B1 (fr) Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires
RU2070409C1 (ru) Препарат для лечения мастита у лактирующих животных
RU2226828C1 (ru) Способ защиты вегетирующих растений от фитофагов
FR3097739B1 (fr) Bactéries du microbiote intestinal et composition en contenant pour son utilisation dans la prévention et/ou le traitement de maladies caractérisées par l’excès de 2-hydroxyglutarate
EA201800384A1 (ru) Средство, обладающее гепатопротекторным, антиоксидантным и цитопротекторным действием
FR3097741B1 (fr) Bactérie du genre Massiliomicrobiota et composition en contenant pour son utilisation comme médicament

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190726

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7